SOURCES OF ERROR IN SEROLOGIC AND IMMUNOLOGIC LAB. Lecture by: Dr. Forouzan Karimi; PharmD, PhD

Transcription

1 SOURCES OF ERROR IN SEROLOGIC AND IMMUNOLOGIC LAB Lecture by: Dr. Forouzan Karimi; PharmD, PhD

2 C-REACTIVE PROTEIN RAPID LATEX AGGLUTINATION TEST

3 SOURCES OF ERROR False-positive results may be observed if: Serum specimens are lipemic, hemolyzed, orheavily contaminated with bacteria. If the reaction time is longer than 2 minutes, afalsepositive result may also be produced from a drying effect. False-negative results may be observed in: Undiluted serum specimens because of high levels of CRP (antigen excess). A 1:5 dilution of serum is also tested for this reason.

4 TRADITIONAL SCREENING TEST FOR INFECTIOUS MONONUCLEOSIS O OS S

5 False-positive reactions have been observed: In conditions such as hepatitis infection and Hodgkin s disease. An improperly inactivated t serum will produce hemolysis (When using RBCs).

6 PREGNANCY LATEX SLIDE AGGLUTINATION

7 TECHNICAL SOURCES OF ERROR Reagents should never be expired; latex reagent must be well shaken and agglutination should be read within 3 minutes to avoid erroneous results caused by evaporation.

8 FALSE-POSITIVE RESULTS If a patient has been given an hcg injection (e.g., Pregnyl) to trigger ovulation or lengthen the luteal phase of the menstrual cycle, trace amounts can remain in the patient s system for as long as 10 days after the last injection. This will produce a false positive result. Two consecutive quantitative hcg blood assays can circumvent this problem. If the hcg level increases by the second test, the patient is probably pregnant. Chorioepithelioma, hydatidiform mole, or excessive ingestion of aspirin may give false-positive results.

9 FALSE-POSITIVE RESULTS (CONT D) In men, a test identical to that used for pregnancy may be performed to detect the presence of a testicular tumor. If Mab against the β subunit is not used, other hormones with the same α unit may cross-reactreact and cause a falsepositive reaction.

10 FALSE-NEGATIVE RESULTS Testing before reaching detectable levels of hcg Testing before reaching detectable levels of hcg will yield false-negative results.

11 ABO BLOOD GROUPING (REVERSE GROUPING) ( )

12 If a patient has been recently transfused with non group specific blood, mixed-field agglutination may be observed. If large quantities of non group-specific blood have been transfused, determination of the correct ABO grouping may be impossible. Discrepancies in forward typing can result from conditions such as weak antigens, altered expression of antigens caused by disease, chimerism, or excessive blood group substances.

13 Excess amounts of blood group specific p soluble substances present in the plasma in certain disorders (e.g., carcinoma of stomach or pancreas) neutralize the reagent anti-a or anti-b, leaving no unbound antibody to react with the patient s erythrocytes. This excess of blood group specific substance produces a false-negative or weak reaction in the forward grouping. If the patient s erythrocytes are washed with saline, the substance should be removed and a correct grouping can be observed.

14 Incorrect typing can also result from additional antigens, caused by the following: Polyagglutinable ygg RBCs Acquired B-like antigen; acquired A-like antigen Complexesp attached to RBCs Agents causing nonspecific erythrocyte agglutination Antibody-sensitized RBCs: effect of colloids and antiantibodies (e.g., hemolytic disease of the newborn, incompatible transfusion, autoimmune ti process)

15 Discrepancies in serum (reverse)grouping g can result from additional or missing antibodies caused by the following: Passively acquired disoagglutinins i Alloantibodies Rouleaux formation Auto anti-i; iso anti-i Anti-A1 in Ax, A2, and A2B blood Anti-H in A1B, A1, B, and Bombay blood Anti-IA and IA

16 CAUSES OF WEAK OR MISSING ANTIBODIES INCLUDE THE FOLLOWING: Deteriorated reagent erythrocytes y Hypogammaglobulinemic Elderly patients Newborn infants Chimerism Rare variants of A or B

17 TECHNICAL SOURCES OF ERROR Each manufacturer provides, with each package of antiserum, detailed instructions for the use of anti-a and anti-b. Because the details vary, it is important to follow the directions for the specific antiserum in use.

18 PROCEDURES THAT APPLY TO ALL TESTS FOR ABO GROUPING INCLUDE THE FOLLOWING: 1. Do not rely on the color of dyes to identify reagent antisera. All tubes must be properly labeled. 2. Do not perform testst at temperaturest higherh than room temperature (20 C to 24 C [68 F to 75 F]). 3. Perform observations of agglutination with a well-lit background. 4. Record results immediately after observation. 5. Remember that contaminated blood specimens, reagents, or supplies may interfere with the test results.

19 LIMITATIONS Antisera prepared p from human sources are capable of detecting A1 and A2 groups. Except in the case of newborn and very young infants, a reverse cell typing should also be performed to verify the results of forward typing.

20 ELECTROPHORESIS TECHNIQUES Sources of Error The prozone phenomenon is an incomplete precipitin reaction caused by antigen excess (antigen-to-antibody t tib ratio too high). h) Prozoning should be suspected if a precipitin arc appears to run into a trough, if an L chain appears fuzzy when an H chain is increased, or if an arc appears to be incomplete.

21 CLASSIC VDRL PROCEDURE: VDRL QUALITATIVE SLIDE TESTS Sources of Error: False-negative reactions can occur in a variety of situations. These include the following: 1. Technical error (e.g., unsatisfactory antigen or technique) 2. Low antibody titers Patients may have syphilis, but the reagin concentration is too low to produce a reactive test result. A low concentration of reagin may be caused by several factors, such as an infection that is too recent to have produced antibodies, the effects of treatment, latent or inactive disease, and patients who have not produced protective antibodies because of immunologic tolerance. These seronegative patients may demonstrate a positive reaction with more sensitive treponemal tests such as the FTA-ABS.

22 3. Presence of inhibitors in the patient s serum 4. Reduced ambient temperature (<23 C to 29 C [<73 F to 84 F]) 5. Prozone reaction

23 A prozone reaction is encountered occasionally. This type of reaction is demonstrated when complete or partial inhibition of reactivity occurs with undiluted serum and minimal reactivity is obtained only with diluted serum. The prozone phenomenon may be so pronounced that only a weakly reactive or rough nonreactive result occurs in the qualitative test by a serum that will be strongly reactive when diluted. It is recommended that all sera producing a weak reaction or rough nonreactive results in qualitative testing be retested with a quantitative procedure before a final report of the VDRL slide test is issued.

24 Weakly reactive results can be caused by the following: 1. Very early infection 2. Lessening of the activity of the disease after treatment 3. Improper technique or questionable reagents False-positive reactions can also occur. Of all positive serologic tests for syphilis, 10% to 30% may be false-positive biologic reactions.

25 Nonsyphilitic positive VDRL reactions have been reported with the cardiolipin type of antigen in the following: 1. Lupus erythematosus 2. Rheumatic fever 3. Vaccinia and viral pneumonia 4. Pneumococcal pneumonia 5. Infectious mononucleosis 6. Infectious hepatitis 7. Leprosy 8. Malaria 9. Rheumatoid arthritis 10. Pregnancy 11. Older individuals

26 Contaminated or hemolyzed specimens can also produce false-positive results Limitations: The VDRL procedure is not specific for syphilis and may demonstrate positive reactions in other reagin-producing disorders, autoimmune disorders, infectious diseases, and in pregnancy or aging in normal physiology.

27 RAPID PLASMA REAGIN CARD TEST Sources of Error Error can be introduced dinto test t results because of ffactors such as contamination ti of rubber bulbs or an improperly prepared antigen suspension. False-positive biological reactions have been reported with cardiolipin type of antigens in the following conditions: Lupus erythematosus Rheumatic fever Vaccinia and viral pneumonia Pneumococcal pneumonia Infectious mononucleosis Infectious hepatitis Leprosy Malaria Rheumatoid arthritis Pregnancy Aging individuals

28 False-negative reactions can result from the following: Poor technique Ineffective reagents Improper rotation Again, if mechanical rotation is below or above the 95- to 110 rpm acceptable range, the clumping of the antigen tends to be less intense in procedures with undiluted specimen; thus, some minimal reactions may be missed. In quantitative tests, rotation above 110 rpm tends to produce a decrease in titer, approximately one dilution lower.

29 LIMITATIONS A diagnosis of syphilis cannot be made based on a single reactive result without clinical signs and symptoms or history. Plasma specimens should not be used to establish a quantitative baseline from which changes in titer can be determined, particularly for evaluating treatment. The RPR cards should not be used for testing CSF. Little reliance should be placed on cord blood serologic testing for syphilis. The RPR procedure has adequate sensitivity and specificity in relation to the clinical diagnosis.

30 PASSIVE LATEX AGGLUTINATION FOR DETECTION OF Sources of Error ANTIBODIES TO CYTOMEGALOVIRUS Incorrect test results may be caused by a variety of factors: Specimens that are incorrectly collected or stored can produce errors in the test results. The use of components or procedures other than those previously described may also lead to erroneous results.

31 LIMITATIONS Several limitations are inherent in CMV antibody detection, as follows: 1. Patients with acute infection may not have detectable antibody. 2. Seroconversion may indicate recent infection, but an increase in antibody titer by this method does not differentiate between a primary and secondary antibody response. 3. The timing of antibody responses during a primary infection may differ slightly. The pattern of antibody response during a primary CMV infection has not been demonstrated. 4. Test results from neonates should be interpreted with caution because the presence of CMV antibody is usually the result of passive transfer from the mother to the fetus.

32 LIMITATIONS 5. Although the CMV latex procedure will detect IgM and IgG antibodies, detection of IgA and IgE antibodies has not yet been demonstrated. t d AnegativeCMVtest result may be useful in excluding possible infection, but the diagnosis of an actual CMV infection should be documented by demonstrating the presence of the virus directly or by viral culture.

33 PAUL-BUNNELL SCREENING TEST Sources of Error False-positive reactions have been observed in conditions such as hepatitis infection and Hodgkin s disease. An improperly inactivated serum will produce hemolysis.

34 MONOSLIDE TEST Sources of Error For accurate results, only clear, particle-free serum or plasma specimens should be used. False-positive results can be caused by the following: 1. Observing agglutination after the observation time 2. Misinterpretingi ti agglutination lti 3. Simultaneous occurrence of infectious mononucleosis and hepatitis has been reported. A result interpreted as a false-positive may be caused by residual heterophile antibody present after clinical symptoms have Sbidd Subsided.

35 WESTERN BLOT The WB technique is time-consuming and expensive. Itisalso open to considerable interpretation and has many sources of error. Variables in the test include the following: The technical skill and experience of the technologist performing the procedure Characteristics of the technical methodology General sensitivity of the WB in detecting antibodies specific for various HIV-1 antigens (especially during the window period of seronegativity) Frequent lack of specificity because of contamination of the viral reference preparation by histocompatibility and other antigens that electrophoretically migrate with p24 and gp41.

36 Variation in band reactivity patterns in sera from an individual id over the course of HIV-1 infection Indeterminate test results account for 4% to 20% of WB assays with positive bands for HIV-1 proteins. Indeterminate WB results can be caused by the following: Serologic tests in the process of seroconversion; anti-p24 is usually the first antibody to appear. End-stage HIV infection, usually with loss of core antibody Cross-reacting nonspecific antibodies, as seen with collagen vascular disease, autoimmune ti diseases, lymphoma, liver disease, injection drug use, multiple sclerosis, parity, or recent immunization Infection with O strain or HIV-2 Recipients of HIV vaccine

37 Perinatally exposed infants who are seroconverting (losing maternal antibody) Technical or clerical error In addition, nonspecific reactions producing indeterminate results in uninfected persons have occurred more frequently in pregnant women or mothers than in persons in other groups characterized by low HIV seroprevalence. The incidence of indeterminate WB results is relatively low. The immunofluorescence assay can be used to resolve an EIA-positive, Wbindeterminate sample.

38 The most important factor in evaluating indeterminate i t results is risk ikassessment. Patients t in low-risk categories with indeterminate test results are almost never infected with HIV-1 or HIV-2. Repeat testing usually continues to show indeterminate esults, and the cause of this pattern is seldom established. Follow-up serology testing at 3 months is recommended d to verify the previous results. Patients t with indeterminate tests who are in the process of seroconversion usually have positive WB test results within 1 month; repeat tests at 1, 2, and 6 months are generally advocated, with appropriate precautions to prevent viral transmission in the interim. False-positive WB results, especially those with a majority of bands, are extremely uncommon.

39 DIRECT ANTIGLOBULIN TEST Sources of Error: False-positive and false-negative results can occur. False-positive results in the DAT can be caused by the following: Contamination of AHG antisera or supplies Overcentrifugation Bacterial contamination of specimen or reagents Fibrin clot in cell suspension False-negative results usually occur because of technical error. Common causes of false-negative reactions include the following: Failure to add AHG reagent Inadequate washing of RBCs WeakorinactiveAHG

40 RAPID SLIDE TEST FOR Sources of Error ANTINUCLEOPROTEIN Failure to observe the test mixture at the appropriate p time can yield false results. Limitations No one test has been shown to be completely reliable for the diagnosis of SLE because many of the ANAs accompanying this disease are also demonstrated in other SRDs, such as rheumatoid arthritis.

41 ANTINUCLEAR ANTIBODY VISIBLE Sources of Error METHOD False-negative results can occur if the ANA happens to be specific for an antigen other than the one used in the procedure. False-negative results may also occur if the substrate is fixed in acetone and is inadequately washed. Without fixation, however, some soluble nuclear antigen may be lost. False-negative results may also be related to the binding of antinuclear factor to circulating immune complexes and to a low antibody titer.

42 ANTINUCLEAR ANTIBODY VISIBLE METHOD (CONT D) False-positive interpretations may occur because of nonspecific staining, which may resemble a speckled pattern of reactivity. These staining i reactions occur whenever the conjugate or serum contains antibodies to other tissue antigens. Careful rinsing and removal of excess fluoresceinated conjugate minimize the risk of some nonspecific staining reactions.

43 Although IIF is considered to be the gold standard, it suffers from being a nonstandardized manual test, has subjective interpretation of results and has low reproducibility. Recently, manufacturers have automated the preevaluation and evaluation phases of IIF ANA testing, including using automatic fluorescent image analysis to provide a virtual titer, which eliminates the process of staining a series of diluted samples manually. EIAs and solid-phase methods (e.g., microarrays and bead-based assays) are popular. However, IIF currently remains the gold standard of testing.

44 Limitations No diagnosis should be based solely on the results of laboratory testing. Clinical data, antibody titers, and other laboratory findings should all be reviewed before a definitive diagnosis is established.

45 REFERENCE: Turgeon ML. Immunology & Serology in g gy gy Laboratory Medicine. 5 th Edition. Elsevier; 2014.